Lyell Immunopharma, Inc.
LYEL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39 | -$43 | -$52 | -$192 |
| Dep. & Amort. | $3 | $3 | $3 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5 | $6 | $0 |
| Change in WC | -$0 | -$1 | -$10 | $0 |
| Other Non-Cash | $8 | $1 | -$2 | $140 |
| Operating Cash Flow | -$29 | -$34 | -$55 | -$47 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$31 |
| Inv. Purchases | -$71 | -$81 | -$84 | -$39 |
| Inv. Sales/Matur. | $74 | $94 | $154 | $124 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3 | $13 | $69 | $54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $50 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $0 |
| Financing Cash Flow | $50 | $0 | $0 | $0 |
| Forex Effect | -$0 | $0 | $0 | -$1 |
| Net Chg. in Cash | $25 | -$22 | $15 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $99 | $122 | $107 | $100 |
| End Cash | $124 | $100 | $122 | $106 |
| Free Cash Flow | -$29 | -$35 | -$55 | -$47 |